Edition:
United States

Verona Pharma PLC (VRNA.OQ)

VRNA.OQ on NASDAQ Stock Exchange Global Market

14.55USD
23 Feb 2018
Change (% chg)

$1.90 (+15.02%)
Prev Close
$12.65
Open
$13.95
Day's High
$14.87
Day's Low
$13.95
Volume
1,429
Avg. Vol
1,256
52-wk High
$17.50
52-wk Low
$10.44

Select another date:

Tue, Feb 13 2018

BRIEF-Verona Pharma Expects To Report Top-Line Data From Phase 2b Trial Of Nebulized RPl554​ Early In Q2

* VERONA PHARMA PLC - ‍ANTICIPATES REPORTING TOP-LINE DATA FROM ITS PHASE 2B TRIAL EARLY IN Q2 OF 2018 FOR NEBULIZED RPL554​

BRIEF-Verona Pharma announces positive top-line data from Phase 2A clinical trial in COPD with RPL554 dosed in addition to Tiotropium

* ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2A CLINICAL TRIAL IN COPD WITH RPL554 DOSED IN ADDITION TO TIOTROPIUM (SPIRIVA) Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: